Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Citi GPS webinar: Foundation to share insights on how responsible investors can help drive change in curbing AMR

Fatema Rafiqi, Research Programme Manager for the Antimicrobial Resistance (AMR) Benchmark, and Investment Engagement Officer Bram Wagner, will join a webinar hosted by Citi GPS focusing on AMR and why investors should consider this global health issue.

Date

14 March 2023

DATE

Tuesday 14 March 2023

TIME

15.00-15.45 CET 

FORMAT

Virtual

In 2022, the Foundation contributed to ‘Antimicrobial Resistance: The Silent Pandemic’, a report launched by Citi Global Perspectives & Solutions (Citi GPS). As part of continued engagement around the report, and to highlight the interventions required by different stakeholders to address AMR, Citi GPS is hosting a series of webinars. These webinars will serve as a platform for report contributors to offer valuable insights on this urgent topic.

Webinar

Fatema and Bram will be discussing the Foundation’s work on AMR, including how investors can use the 2021 AMR Benchmark to support their engagements with companies across the pharmaceutical industry.

They will also address issues that investors can consider to help incentivise pharmaceutical companies to take action in tackling this urgent global health issue:

  • Why AMR is a topic that responsible investors should consider.

  • The critical path to incentivising pharmaceutical companies to do more to innovate for novel antimicrobials.

  • How responsible manufacturing of antimicrobials can prevent AMR.

  • Why improving access to medicine can play a role in addressing AMR.

  • Understanding what constitutes good stewardship of antimicrobials.

Read more about the Foundation's work on AMR

Click here for our AMR Research Programme, or here for the Investor Action on AMR progress report.

Camille Creisson

Events Coordinator

events@accesstomedicinefoundation.org

Get in touch

Resource Centre

Learn more about our work on AMR
Research

Investor Action on Antimicrobial Resistance progress report

21 November 2022
Research

Lack of access to medicine is a major driver of drug resistance. How can pharma take action?

27 October 2022
Research

Biotechs are saving the world from superbugs. Can they also save themselves?

10 June 2021

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved